We evaluated the in vivo efficacy of human-simulated WCK 5222 (cefepime-zidebactam) against cefepime-resistant Acinetobacter baumannii strains ( n = 13) in the neutropenic murine lung infection model. Twelve isolates were meropenem resistant.
No takes yet. Share an insight, caveat, or question.
Avery et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: